Colloidal Bismuth Subcitrate in the Treatment of Helicobacter Pylori Infection
Journal Title: Гастроентерологія - Year 2016, Vol 1, Issue 59
Abstract
The article deals with the treatment of Helicobater pylori infection. We consider the regimens, which are currently recommended for use and matched the recent data of evidence-based medicine. According to a survey conducted in 2015 in Ukraine, first-line quadruple therapy with the inclusion of bismuth subcitrate showed the effectiveness of more than 90 % in the Eastern and Central regions of the country; the superiority of bismuth-containing regimen over the standard one (89 and 55 % of the successful eradications, respectively) has been also demonstrated. This paper presents the results of research on the effectiveness of first-line anti-Helicobacter pylori therapy consisting of a proton pump inhibitor, clarithromycin, amoxicillin with the addition of colloidal bismuth subcitrate (De Nol) in patients at high risk of developing resistance to clarithromycin. In the group of patients at high risk of resistance to clarithromycin, addition to the standard triple therapy of colloidal bismuth subcitrate has led to an increase in the effectiveness of eradication by 22.1 %, which indicates the feasibility of colloidal bismuth subcitrate (De Nol) inclusion into the treatment regimen for this category of patients.
Authors and Affiliations
A. E. Dorofeiev, M. M. Rudenko, A. V. Sibiliov
Keywords
Related Articles
- EP ID EP209595
- DOI -
- Views 108
- Downloads 0
Research scientist Dmytro Yavornytskyi in the society of doctors
Relations of the researcher of Zaporizhzhia Cossacks, academician Dmytro Yavornytskyi, with representatives of the medical society have been studied. The influence of D. Yavornytskyi on the views, public position of medi...
Safety and Potential Risks of Prolonged Use of Proton Pump Inhibitors
Article deals with the use of proton pump inhibitors in gastroenterology. We considered the impact of proton pump inhibitors on of a variety of processes in the body, such as the absorption of vitamins and minerals, oste...
Dynamics of Serum Pepsinogens on the Background of Double Standard Doses of Omeprazole in Patients with Gastroesophageal Reflux Disease and Functional Gastric Dyspepsia
In literature it has been reported that concentrations of serum pepsinogens increase during administration of proton pump inhibitors (PPI). However, the magnitude of these changes is still to be assessed. The aim of this...
Modern Possibilities of Bismuth Preparations in Patients with Gastroduodenal Pathology
There are presented modern data about the mechanisms of colloidal bismuth subcitrate effects on the gastroduodenal mucosa and place of bismuth preparations in therapeutic regimens for Helicobacter pylori infection based...
Age-related and gender features of circulating immune complexes and lipid metabolism in inflammatory bowel diseases
Background. The purpose of the present work was to assess the level of circulating immune complexes (CIC) and lipid metabolism state in patients with inflammatory bowel disease (IBD). Materials and methods. We examined...